4/A: Mannatech CFO Amends Stock Option Vesting Schedule
Amendment to Statement of Changes in Beneficial Ownership
Mannatech Inc.'s Chief Financial Officer, James Clavijo, filed an amended Form 4 to correct the vesting schedule for 10,000 stock options.
Summary
- James Clavijo, Chief Financial Officer of Mannatech Inc. (MTEX), filed an amended Form 4/A.
- The amendment corrects the vesting schedule for 10,000 derivative securities (stock options) granted on June 3, 2025.
- The original Form 4, filed on June 5, 2025, contained an incorrect vesting schedule.
- The corrected vesting schedule states that one-third of the stock options vest on the first anniversary of the grant date, another one-third on the second anniversary, and the remaining one-third on the third anniversary.
- The stock options have an exercise price of $10.6 per share and expire on June 3, 2035.
- Following this reported transaction, James Clavijo beneficially owns 14,500 derivative securities.
- A clause specifies that the options will vest immediately in the event of a change in control.
Sentiment
Score: 5
Explanation: The filing is neutral as it is an administrative correction of a previously reported transaction. It clarifies executive compensation details without indicating any operational or financial performance changes.
Positives
- The grant of 10,000 stock options to the Chief Financial Officer aligns executive incentives with shareholder value over a multi-year period.
- The immediate vesting upon a change in control provides an incentive for the executive during potential acquisition scenarios.
Negatives
- The need for an amendment indicates an initial administrative error in the original filing regarding the vesting schedule.
Future Outlook
The corrected vesting schedule for the stock options indicates a commitment to retaining the Chief Financial Officer over a three-year period, with the options vesting annually. The immediate vesting upon a change in control provides a clear incentive structure for potential future corporate events.
Industry Context
The grant of stock options with a multi-year vesting schedule is a common practice in executive compensation across various industries. It serves to align the interests of key management personnel with the long-term performance of the company and shareholder value. The inclusion of a change-in-control clause is also standard in many executive compensation agreements.
Comparison to Industry Standards
- The three-year annual vesting schedule for executive stock options is a common industry standard, comparable to practices at companies like Apple, Microsoft, or Google for their senior executives, designed to promote long-term retention and performance alignment.
- An immediate vesting clause upon a change in control is also a standard feature in executive compensation packages, often referred to as 'double-trigger' or 'single-trigger' provisions, seen in a wide range of public companies to protect executive interests during mergers or acquisitions.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Correction to Executive Compensation Disclosure | An amendment was filed to correct the vesting schedule of stock options granted to the Chief Financial Officer, ensuring accurate public disclosure of executive compensation terms. | 06/03/2025 (original grant date) | Enhances transparency and accuracy of executive compensation reporting, which is a core aspect of corporate governance. The initial error, while corrected, highlights the importance of meticulous filing procedures. |
Stakeholder Impact
- Shareholders: Provides clarity on the long-term incentive structure for a key executive, aligning their interests with the company's performance over time.
- Employees: No direct impact on general employees, but reinforces the company's executive compensation practices.
Next Steps
- One-third of the stock options will vest on the first anniversary of the grant date (June 3, 2026).
- Another one-third of the stock options will vest on the second anniversary of the grant date (June 3, 2027).
- The remaining one-third of the stock options will vest on the third anniversary of the grant date (June 3, 2028).
Key Dates
| Date | Description |
|---|---|
| 06/03/2025 | Date of earliest transaction (grant date of stock options) |
| 06/05/2025 | Date of original Form 4 filing with incorrect vesting schedule |
| 08/28/2025 | Signature date of the amended Form 4/A |
| 06/03/2035 | Expiration date of the stock options |
Keywords
Mannatech, MTEX, James Clavijo, CFO, Stock Options, Form 4/A, SEC Filing, Executive Compensation, Vesting Schedule, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.